Harvard Bioscience Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
17 Aug 23 | BuyUS$109,500 | James Green | Individual | 25,000 | US$4.38 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 2,765 | 0.00637% |
Individual Insiders | 3,055,053 | 7.04% |
Hedge Funds | 5,247,900 | 12.1% |
General Public | 6,730,728 | 15.5% |
Institutions | 28,384,805 | 65.4% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 2.9%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
2,939,278 | US$11.2m | -9.92% | 4.82% | |||
2,918,034 | US$11.1m | -0.17% | 0.61% | |||
2,913,814 | US$11.1m | 6.24% | no data | |||
2,557,500 | US$9.8m | 0% | 1.1% | |||
2,308,622 | US$8.8m | 6.74% | 10.94% | |||
2,102,571 | US$8.0m | 1.85% | no data | |||
1,925,635 | US$7.4m | -0.43% | no data | |||
1,878,749 | US$7.2m | 0% | no data | |||
1,843,484 | US$7.0m | 6.22% | 0.24% | |||
1,450,829 | US$5.5m | 2.85% | 0.05% | |||
1,362,019 | US$5.2m | 6.87% | 0.21% | |||
1,009,850 | US$3.9m | -5.08% | 0.01% | |||
866,467 | US$3.3m | 0% | 0.17% | |||
819,750 | US$3.1m | 1.57% | 1.48% | |||
804,636 | US$3.1m | 3.42% | no data | |||
720,378 | US$2.8m | -3.26% | no data | |||
682,423 | US$2.6m | 2.15% | no data | |||
672,170 | US$2.6m | 49.1% | 0.18% | |||
468,117 | US$1.8m | 0% | no data | |||
467,648 | US$1.8m | 0.2% | no data | |||
364,409 | US$1.4m | 0% | 0.03% | |||
326,516 | US$1.2m | 35.1% | 0.44% | |||
326,285 | US$1.2m | -1.53% | 0.03% | |||
285,422 | US$1.1m | -0.17% | 0.39% | |||
279,358 | US$1.1m | 0% | 0.47% |